PREDICTIVE FACTORS OF SURVIVAL TIME AFTER HEMATOPOIETIC STEM CELL TRANSPLANT IN ACUTE MYELOID LEUKEMIA PATIENTS WHO RECEIVED ALLOGENEIC BMT FROM MATCHED SIBLING DONORS USING GENERALIZED GAMMA MODELS